□ 本报记者 李嘉豪 2月3日，江苏省十四届人大五次会议在南京开幕。开幕会前，9位省人大代表走上"代表通道"接受记者 采访，分享各自履职路上的实干故事，娓娓道来江苏各行各业乘风破浪的奋进历程。相较去年首次开展 的采访活动，今年亮相代表人数更多，关注话题与履职实践覆盖科技自立自强、民营经济高质量发展、 构建良好教育生态、创新优化文化产品供给、激发共建共治共享活力、全面推进乡村振兴等重点领域。 一个个乘风破浪的故事，勾勒出高质量发展的生动图景和铿锵印迹。 省人大代表、南京南瑞继保电气有限公司总经理李九虎作为首位接受采访代表，分享了电力核心技术攻 关的筚路蓝缕。"电力行业有两项牵一发而动全身的关键技术，一个是继电保护，产品曾高度依赖进 口，另一个是特高压输电，是持续攻关的难题。"他介绍，如今我国新建工程继电保护国产化率已达 100%，国际公认最好的继电保护在中国。特高压技术创造12项世界第一，支撑"西电东送"工程满足中 东部地区1/5的用电。"人工智能时代，能源是底层基石，我们将鼓足干劲，为建设能源强省、能源强国 作出更大贡献！" 针对"送文化下乡"节目"不合群众胃口"的问题，省人大代表、沛县文化馆馆长王宝红走访全 ...

Core Insights - Swisse has celebrated its 10th anniversary in the Chinese market, reflecting on its past achievements and future growth strategies under the theme "Collaborate for Win-Win, Steady Growth" [1] - The company has evolved from an Australian brand to a global health leader, maintaining a strong focus on consumer health trends and local market needs [3][4] Group 1: Company Growth and Strategy - Swisse has experienced significant growth through two key phases: the 1.0 era capitalizing on the rise of cross-border e-commerce and the 2.0 era focusing on local market adaptation and product diversification [4][5] - The brand has launched multiple product lines, including Little Swisse for children and Swisse Me for young adults, addressing the diverse nutritional needs of various consumer segments [5] - In 2023, Swisse introduced the "Swisse Mega Brand" strategy, achieving a global sales milestone of over 1 billion AUD and becoming the top nutrition brand in China [7] Group 2: Consumer Insights and Product Development - The company has adapted to the evolving consumer demand for personalized, scientific, and age-specific nutrition, moving beyond basic supplementation [8] - Swisse emphasizes its commitment to quality through its "Three Truths" philosophy: true reputation, true effectiveness, and true safety, ensuring consumer trust and product integrity [10] Group 3: Future Directions and Partnerships - Swisse aims to strengthen its ecosystem with partners, focusing on long-term collaboration, product quality, and transparent communication [13][14] - The company plans to continue innovating based on consumer insights and maintain compliance with scientific standards, enhancing brand and channel synergy [14][18]

Core Viewpoint The article discusses the financial practices and market position of Yuwang Biological Nutrition Co., Ltd., highlighting concerns over its recent dividend distribution and the implications for its upcoming IPO. Industry Overview - The global nutritional supplement industry is rapidly growing, with fish oil being a significant segment due to its health benefits across all age groups [2][44]. - Fish oil is rich in Omega-3 fatty acids, which help reduce cardiovascular risks in the elderly and have potential benefits for brain health [2][44]. - The global market for human-grade fish oil is expected to grow at a compound annual growth rate (CAGR) of 8.89%, reaching $990 million by 2029 [2][44]. Company Overview - Yuwang Biological has submitted an IPO application to the Hong Kong Stock Exchange, citing several funding needs for expansion and operations [5][6]. - The company distributed a significant dividend of 320 million yuan just before filing for the IPO, which is equivalent to its total profit over the past three and a half years [7][11]. - The company has a high debt ratio exceeding 80%, with cash reserves insufficient to cover the recent dividend payout [12][15]. Financial Performance - Yuwang Biological reported a revenue increase from 534 million yuan in 2022 to 832 million yuan in 2024, with a CAGR of 24.8% [22][62]. - However, in the first half of 2025, the company experienced a 27% decline in revenue to 343 million yuan and a 74% drop in profit to 23 million yuan [24][64]. - The gross margin fell to 20.74% in the first half of 2025, a nearly 9 percentage point decrease from the previous year [25][65]. Market Position - Yuwang Biological claims to be the largest supplier of food-grade refined fish oil, holding an 8.12% market share [18][58]. - The overall market concentration is low, with the top five companies holding only 32.37% of the market, indicating intense competition [18][58]. - The global fish oil market is currently valued at just over $800 million, with limited growth potential [21][61]. Challenges - The company faces significant challenges due to high raw material costs and price volatility, as fish oil prices have fluctuated dramatically [27][71]. - Yuwang Biological's reliance on fish oil for over 98% of its revenue makes it vulnerable to supply chain disruptions and price increases [67][72]. - The company has seen a substantial loss of customers, with domestic clients decreasing from 310 to 190 and international clients from 240 to 190 in the first half of 2025 [36][76]. Brand and Sales Strategy - Yuwang Biological has shifted focus from building its own brand to acting as an OEM for international dietary supplement brands, with over 60% of revenue coming from overseas [34][74]. - The company has increased marketing expenditures but has seen limited success in building its consumer brand, with only 2.1% of total revenue coming from direct consumer sales [38][78].

Core Viewpoint - The company reported a total revenue of 10.81 billion RMB for the first three quarters of 2025, reflecting a year-on-year increase of 12.3%, with all business segments showing positive growth [1] Revenue Breakdown - The adult nutrition and care products segment saw a revenue increase of 6.0% year-on-year [1] - The infant nutrition and care products segment experienced a significant revenue growth of 24.0%, with infant formula revenue rising by 33.3% [1] - The pet nutrition and care products segment recorded a revenue increase of 8.2% year-on-year [1] Regional Performance - Domestic revenue for the adult nutrition and care segment grew by 15.7%, with cross-border e-commerce revenue increasing by 23.1% and Douyin revenue soaring by 77.7% [1] - Revenue from Australia declined by 19.4%, attributed to the company's proactive adjustment of purchasing channels, while local growth in Australia was 8.9% [1] - Other regions saw a revenue increase of 19%, mainly driven by high growth in nine emerging markets in Asia [1] Brand Performance - The company's brand, Biostime, achieved a market share of 16.4% in the ultra-premium infant formula market, with a quarterly share of 17.3% in Q3 2025 [1] - The decline in probiotic revenue has narrowed, likely due to new product promotions and the stabilization of pharmacy channels [1] Financial Position - The company ended Q3 2025 with a cash balance of 1.74 billion RMB after repaying 150 million RMB equivalent in USD debt, indicating a strong financial position [1] - Overall, the company is expected to maintain positive growth across multiple business segments, positioning itself as a long-term supplier of nutrition products for all family members [1] Profit Forecast - The company is projected to achieve a net profit attributable to shareholders of 518 million RMB, 672 million RMB, and 781 million RMB for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 16, 12, and 11 times [2]

Core Viewpoint - H&H International Holdings reported a 12% year-on-year increase in revenue for the first nine months of the year, driven by strong performance in the nutritional supplements segment, which accounted for 64.5% of total revenue [1] Financial Performance - Revenue for the first nine months reached 10.805 billion RMB, with a reported year-on-year increase of 12% and a like-for-like increase of 12.3% [1] - The nutritional supplements segment, which has a higher profit margin, contributed significantly to the revenue, while vitamin, herbal, and mineral supplements grew by 6% and pet nutrition products increased by 14.2% on a like-for-like basis [1] Market Outlook - The company expects continued growth in the adult nutrition and care products segment in China [1] - For the infant nutrition and care products segment, sales of infant formula are anticipated to maintain growth due to e-commerce and marketing activities in specialized baby stores [1] - In the pet nutrition and care products segment, SolidGold is expected to sustain its momentum by focusing on high-end pet food and nutrition products while enhancing its presence in cross-border e-commerce channels [1]

Core Insights - The article highlights the global launch of Witsbb's eye and brain DHA product specifically designed for children aged 3-12, showcasing the effectiveness of the China International Import Expo as a platform for innovation and market entry [1][2][8] Group 1: Product Innovation - Witsbb's new DHA product is the only one on the market specifically designed for school-age children and boasts nine global patents, indicating a shift towards more specialized and refined nutritional products [2][3] - The product features a high purity level of 80% for its patented algal oil DHA and utilizes an rTG structure, which is more efficiently absorbed by the body compared to traditional EE fish oil DHA [4][5] Group 2: Market Demand - There is an unprecedented focus among Chinese families on children's health, particularly regarding eye and brain health, driven by increased academic pressure and screen time [3][8] - The product's popularity is rooted in its scientific foundation, addressing specific pain points in children's health and learning capabilities [3][4] Group 3: Marketing and Distribution - The launch at the expo and its coverage by CCTV News exemplify the effective transition from exhibition to consumer availability, enhancing the product's visibility and market penetration [7][8] - The collaboration between the expo and authoritative media platforms accelerates the introduction of innovative products into the Chinese market, reflecting a broader trend towards high-quality development driven by technology and patent barriers [8]

Core Insights - The article discusses the evolving consumer trends observed at the China International Import Expo (CIIE), highlighting a shift towards self-pleasure and emotional value in purchasing decisions, particularly in luxury goods and lifestyle products [5][10]. Group 1: Consumer Trends - The motivation for purchasing luxury goods has shifted from showcasing status to seeking personal happiness, with "self-pleasure" and "emotional value" becoming key drivers in consumer decision-making [5]. - The rise of the "pet economy" is evident, with a dedicated pet-themed exhibition area at CIIE, reflecting the growing demand for pet-related products and services [9]. - The trend of "active health management" is emerging, with consumers increasingly seeking products that offer tangible health benefits rather than just marketing concepts [10]. Group 2: Company Innovations - Bulgari introduced "Connected Jewelry," allowing consumers to trace the origins and quality of gemstones, enhancing trust and experience [6]. - Pop Mart showcased immersive experiences with popular IPs, indicating a global trend towards emotional value in consumer products [7]. - LEGO created a "City Walk" experience at CIIE, emphasizing play as a universal language and appealing to both local and international audiences [8]. Group 3: Health and Wellness - Inne, a German nutrition brand, reported significant growth in children's nutritional products, indicating a shift towards proactive health management among consumers [10]. - The introduction of innovative health products, such as liquid calcium, reflects the changing focus from traditional supplements to more comprehensive health solutions [10]. - The demand for high-quality, personalized healthcare solutions is increasing, particularly among the aging population, as seen in the offerings from Edward Lifesciences [13][14]. Group 4: Aging Population - The CIIE highlighted the "silver economy," showcasing products designed for the elderly, including safety and wellness solutions [12]. - Companies are increasingly focusing on the unique healthcare needs of older adults, with innovations aimed at improving their quality of life [14]. - The introduction of AI-driven interactive robots for elderly care reflects the growing emphasis on emotional support and safety monitoring for seniors [14].

Group 1: Consumer Trends - The core consumer motivation has shifted from showcasing wealth to seeking personal happiness, with "self-pleasure" and emotional value becoming key drivers in purchasing decisions [2][3] - The pet economy is thriving, with the establishment of a dedicated pet-themed exhibition area at the expo, reflecting the growing demand for pet-related products and services [5] - The trend of "self-pleasure" and emotional value is also evident in the rise of immersive experiences and personalized products, as seen with brands like LEGO and Brother [4][6] Group 2: Health and Wellness - Consumers are increasingly proactive about health management, moving from passive responses to active engagement, as demonstrated by the success of innovative health products at the expo [7][8] - The demand for high-quality, effective health products is rising, with a notable increase in inquiries about clinical efficacy at the expo [7] - The introduction of new health products, such as liquid calcium for both mothers and infants, indicates a shift towards comprehensive health solutions [7] Group 3: Aging Population - The expo highlighted the "silver economy," showcasing products and services tailored for the aging population, including rehabilitation aids and home safety solutions [9][10] - Companies are focusing on personalized treatment options for age-related health issues, particularly in the field of cardiac care, to meet the unique needs of Chinese patients [10][11] - Innovations like interactive robots aimed at providing companionship and safety for the elderly reflect the growing attention to emotional and practical needs in the aging demographic [11]

Core Viewpoint - Xinhecheng (002001) focuses on two main sectors: nutrition and health, and high polymer new materials, emphasizing an integrated, series, and collaborative development strategy [1] Group 1: Business Strategy - The company aims to leverage its advantages in "technology + resources + market" to achieve a series, scale, and high value-added layout [1] - Xinhecheng is committed to extending the industrial chain around its existing business segments, fostering synergistic effects with its current industries [1] Group 2: Research and Development - All segments of the company are advancing research and development projects, indicating a rich reserve of projects [1]

Financial Performance - In Q3 2025, the company achieved a revenue of 166.42 billion CNY, with a net profit attributable to shareholders of 55.41 billion CNY, reflecting a year-on-year revenue growth of 5.45% and a net profit increase of 33.37% [3] - The company has maintained steady growth through production and sales linkage, market expansion, and cost control measures [3] Product Development and Market Strategy - The company focuses on the "Chemical+" and "Biological+" strategies, targeting opportunities in nutrition products, new materials, flavoring agents, and active pharmaceutical ingredients [3] - In the human nutrition sector, the company offers a range of products including vitamins A, D3, E, C, coenzyme Q10, taurine, β-carotene, and lycopene, with a commitment to customized formulations for various applications [3] - The solid methionine production capacity is currently at 30,000 tons, with an expansion project underway [3] Strategic Partnerships and Projects - The company has partnered with Sinopec to establish a joint venture for a liquid methionine project, with a production capacity of 18,000 tons/year [3] - The nylon new materials project in Tianjin has commenced construction, focusing on an integrated production chain from adiponitrile to nylon 66 [4] Future Plans and Innovations - The company aims to enhance its core competitiveness in the new materials sector by developing high-performance polymers and key intermediates [4] - The company is expanding its flavor and fragrance segment, with plans for a new fragrance industrial park in Shandong [4] - The Heilongjiang base is focused on bio-fermentation products, with ongoing improvements in product lines and operational efficiency [4] International Expansion - Over 50% of the company's sales are from international markets, with established subsidiaries in regions including Hong Kong, Singapore, Germany, Mexico, Brazil, Japan, and Vietnam [6] - The company emphasizes overseas market expansion as part of its 2025 operational strategy [6] Employee Engagement and Incentives - The company is implementing a share buyback program with a total amount between 30 million to 360 million CNY, aimed at employee stock ownership plans to enhance motivation and align interests [6]